Cutaneous T-cell lymphoma (CTCL) may present with eczematous lesions, mycosis fungoides (MF), or as exfoliative erythroderma with circulating atypical cells, Sezary syndrome (SS). The 'malignant' T cells are epidermotropic and clonal, but whether they respond to antigen stimulation is unknown. Because CD4+ lymphocytes recognize antigen presented by histocompatibility locus antigen (HLA) class II molecules, and HLA associations have been found in autoimmune skin diseases, we determined by allele-specific oligonucleotide typing whether HLA-DR or DQ alleles were associated with CTCL and its two variants MF (n = 47) and SS (n = 23). Phenotypic frequencies were compared by chi-square and Fisher exact test, and p values were corrected independently for either 12 DR or 15 DQ alleles. HLA-DR5, previously associated with MF, was significantly increased in all 70 CTCL patients (31.5%) versus controls (11%) (uncorrected p value [p(nc)] = 0.000038, odds ratio [OR] = 3.9, 1.9
CITATION STYLE
Jackow, C. M., Mc Ham, J. B., Friss, A., Alvear, J., Reveille, J. R., & Duvic, M. (1996). HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma. Journal of Investigative Dermatology, 107(3), 373–376. https://doi.org/10.1111/1523-1747.ep12363352
Mendeley helps you to discover research relevant for your work.